142 related articles for article (PubMed ID: 28405918)
1. Hepcidin suppression in β-thalassemia is associated with the down-regulation of atonal homolog 8.
Upanan S; McKie AT; Latunde-Dada GO; Roytrakul S; Uthaipibull C; Pothacharoen P; Kongtawelert P; Fucharoen S; Srichairatanakool S
Int J Hematol; 2017 Aug; 106(2):196-205. PubMed ID: 28405918
[TBL] [Abstract][Full Text] [Related]
2. The transcription factor ATOH8 is regulated by erythropoietic activity and regulates HAMP transcription and cellular pSMAD1,5,8 levels.
Patel N; Varghese J; Masaratana P; Latunde-Dada GO; Jacob M; Simpson RJ; McKie AT
Br J Haematol; 2014 Feb; 164(4):586-96. PubMed ID: 24236640
[TBL] [Abstract][Full Text] [Related]
3. Hepcidin levels and iron status in beta-thalassemia major patients with hepatitis C virus infection.
Hendy OM; Allam M; Allam A; Attia MH; El Taher S; Eldin MM; Ali A
Egypt J Immunol; 2010; 17(2):33-44. PubMed ID: 23082485
[TBL] [Abstract][Full Text] [Related]
4. mRNA expression of iron regulatory genes in beta-thalassemia intermedia and beta-thalassemia major mouse models.
Weizer-Stern O; Adamsky K; Amariglio N; Rachmilewitz E; Breda L; Rivella S; Rechavi G
Am J Hematol; 2006 Jul; 81(7):479-83. PubMed ID: 16755567
[TBL] [Abstract][Full Text] [Related]
5. Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia.
Kautz L; Jung G; Du X; Gabayan V; Chapman J; Nasoff M; Nemeth E; Ganz T
Blood; 2015 Oct; 126(17):2031-7. PubMed ID: 26276665
[TBL] [Abstract][Full Text] [Related]
6. Hepcidin expression from monocyte of splenectomized and non-splenectomized patients with HbE-β-thalassemia.
Pratummo K; Jetsrisuparb A; Fucharoen S; Tripatara A
Hematology; 2014 Apr; 19(3):175-80. PubMed ID: 23905873
[TBL] [Abstract][Full Text] [Related]
7. Modulation of hepcidin expression by normal control and beta0-thalassemia/Hb E erythroblasts.
Jaratsittisin J; Sornjai W; Svasti S; Fucharoen S; Roytrakul S; Smith DR
Hematology; 2018 Aug; 23(7):423-428. PubMed ID: 29157161
[TBL] [Abstract][Full Text] [Related]
8. Hepcidin gene polymorphisms and iron overload in β-thalassemia major patients refractory to iron chelating therapy.
Zarghamian P; Azarkeivan A; Arabkhazaeli A; Mardani A; Shahabi M
BMC Med Genet; 2020 Apr; 21(1):75. PubMed ID: 32268883
[TBL] [Abstract][Full Text] [Related]
9. Relation of hepcidin gene expression in blood mononuclear cells with iron overload severity among β-thalassemia major patients.
Ayatollahi H; Mousavi Nezhad SF; Talebpour A; Badiei Z; Nezami H
Mol Biol Rep; 2020 Dec; 47(12):9353-9359. PubMed ID: 33231816
[TBL] [Abstract][Full Text] [Related]
10. Peripheral expression of hepcidin gene in Egyptian β-thalassemia major.
Aboul-Enein A; El-Beshlawy A; Hamdy M; Shaheen I; El-Saadany Z; Samir A; El-Samie HA
Gene; 2015 Jun; 564(2):206-9. PubMed ID: 25816754
[TBL] [Abstract][Full Text] [Related]
11. Hepcidin is suppressed by erythropoiesis in hemoglobin E β-thalassemia and β-thalassemia trait.
Jones E; Pasricha SR; Allen A; Evans P; Fisher CA; Wray K; Premawardhena A; Bandara D; Perera A; Webster C; Sturges P; Olivieri NF; St Pierre T; Armitage AE; Porter JB; Weatherall DJ; Drakesmith H
Blood; 2015 Jan; 125(5):873-80. PubMed ID: 25519750
[TBL] [Abstract][Full Text] [Related]
12. Generation of a Conditional Allele of the Transcription Factor Atonal Homolog 8 (Atoh8).
Ejarque M; Mir-Coll J; Gomis R; German MS; Lynn FC; Gasa R
PLoS One; 2016; 11(1):e0146273. PubMed ID: 26752640
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the transcriptional activity of the basic helix-loop-helix (bHLH) transcription factor Atoh8.
Ejarque M; Altirriba J; Gomis R; Gasa R
Biochim Biophys Acta; 2013 Nov; 1829(11):1175-83. PubMed ID: 23938248
[TBL] [Abstract][Full Text] [Related]
14. Correlation of hepcidin level with insulin resistance and endocrine glands function in major thalassemia.
Al-Hakeim HK; Al-Khakani MM; Al-Kindi MA
Adv Clin Exp Med; 2015; 24(1):69-78. PubMed ID: 25923089
[TBL] [Abstract][Full Text] [Related]
15. Suppression of Growth Differentiation Factor 15 Gene Expression by Curcumin in Patients with Beta-Thalassemia Intermedia.
Saeidnia M; Ghaderi A; Erfani M; Nowrouzi-Sohrabi P; Shokri M; Tamaddon G; Karimi M; Babashahi M
Clin Lab; 2024 Jan; 70(1):. PubMed ID: 38213217
[TBL] [Abstract][Full Text] [Related]
16. Hepcidin and 1,25(OH)2D3 effectively restore Ca2+ transport in β-thalassemic mice: reciprocal phenomenon of Fe2+ and Ca2+ absorption.
Kraidith K; Svasti S; Teerapornpuntakit J; Vadolas J; Chaimana R; Lapmanee S; Suntornsaratoon P; Krishnamra N; Fucharoen S; Charoenphandhu N
Am J Physiol Endocrinol Metab; 2016 Jul; 311(1):E214-23. PubMed ID: 27245334
[TBL] [Abstract][Full Text] [Related]
17. Urinary hepcidin in congenital chronic anemias.
Kearney SL; Nemeth E; Neufeld EJ; Thapa D; Ganz T; Weinstein DA; Cunningham MJ
Pediatr Blood Cancer; 2007 Jan; 48(1):57-63. PubMed ID: 16220548
[TBL] [Abstract][Full Text] [Related]
18. Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin.
Gardenghi S; Marongiu MF; Ramos P; Guy E; Breda L; Chadburn A; Liu Y; Amariglio N; Rechavi G; Rachmilewitz EA; Breuer W; Cabantchik ZI; Wrighting DM; Andrews NC; de Sousa M; Giardina PJ; Grady RW; Rivella S
Blood; 2007 Jun; 109(11):5027-35. PubMed ID: 17299088
[TBL] [Abstract][Full Text] [Related]
19. A low-molecular-weight compound K7174 represses hepcidin: possible therapeutic strategy against anemia of chronic disease.
Fujiwara T; Ikeda T; Nagasaka Y; Okitsu Y; Katsuoka Y; Fukuhara N; Onishi Y; Ishizawa K; Ichinohasama R; Tomosugi N; Harigae H
PLoS One; 2013; 8(9):e75568. PubMed ID: 24086573
[TBL] [Abstract][Full Text] [Related]
20. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin.
Tanno T; Bhanu NV; Oneal PA; Goh SH; Staker P; Lee YT; Moroney JW; Reed CH; Luban NL; Wang RH; Eling TE; Childs R; Ganz T; Leitman SF; Fucharoen S; Miller JL
Nat Med; 2007 Sep; 13(9):1096-101. PubMed ID: 17721544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
